VK2735 shows strong early weight loss data, positioning Viking Therapeutics as a potential third major player in the booming GLP-1 obesity drug market. Learn more on VKTX stock here.

While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ...

MLCO rides Macau's tourism rebound with strong first-quarter results, but faces rising competition and top-line ...

Are you ready to celebrate the big and beautiful? An often overlooked group in the drag and burlesque communities is those ...

Why is the Special Intensive Revision in Bihar relevant to the UPSC exam? What is the significance of topics such as the ...